Scholars@Duke

Caspofungin versus amphotericin B for invasive candidiasis.

Publication ,  Journal Article
Brown, AL; Greig, JR
Published in: N Engl J Med
March 27, 2003
Published version (DOI) Link to item

Duke Scholars

John Robert Perfect
Author John Robert Perfect Medicine, Infectious Diseases

Published In

N Engl J Med

DOI

10.1056/NEJM200303273481315

EISSN

1533-4406

Publication Date

March 27, 2003

Volume

348

Issue

13

Start / End Page

1287 / 1288

Location

United States

Related Subject Headings

  • Peptides, Cyclic
  • Peptides
  • Lipopeptides
  • Humans
  • General & Internal Medicine
  • Fluconazole
  • Echinocandins
  • Drug Resistance, Fungal
  • Caspofungin
  • Candidiasis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brown, A. L., & Greig, J. R. (2003). Caspofungin versus amphotericin B for invasive candidiasis. N Engl J Med, 348(13), 1287–1288. https://doi.org/10.1056/NEJM200303273481315
Brown, Adam L., and James R. Greig. “Caspofungin versus amphotericin B for invasive candidiasis.” N Engl J Med 348, no. 13 (March 27, 2003): 1287–88. https://doi.org/10.1056/NEJM200303273481315.
Brown AL, Greig JR. Caspofungin versus amphotericin B for invasive candidiasis. N Engl J Med. 2003 Mar 27;348(13):1287–8.
Brown, Adam L., and James R. Greig. “Caspofungin versus amphotericin B for invasive candidiasis.” N Engl J Med, vol. 348, no. 13, Mar. 2003, pp. 1287–88. Pubmed, doi:10.1056/NEJM200303273481315.
Brown AL, Greig JR. Caspofungin versus amphotericin B for invasive candidiasis. N Engl J Med. 2003 Mar 27;348(13):1287–1288.

Published In

N Engl J Med

DOI

10.1056/NEJM200303273481315

EISSN

1533-4406

Publication Date

March 27, 2003

Volume

348

Issue

13

Start / End Page

1287 / 1288

Location

United States

Related Subject Headings

  • Peptides, Cyclic
  • Peptides
  • Lipopeptides
  • Humans
  • General & Internal Medicine
  • Fluconazole
  • Echinocandins
  • Drug Resistance, Fungal
  • Caspofungin
  • Candidiasis